Value Plus

Arihant's Value Plus – October 2017

Market Outlook October: Going ahead, Indian equity markets will remain volatile this month due to ongoing geopolitical tensions between the US and North Korea. Investors will closely watch developments in North Korea. The recent declines in the stock market, which were triggered by geopolitical tensions, aggravated on worries about a further delay in corporate earnings revival. Apart from this, RBI monetary policy, Q2FY18 corporate earnings, US FOMC meeting minutes, ECB monetary policy, BOJ monetary Policy, FIIs trend, currency movement and crude oil price movement will be the major factors to watch out for. Investors should invest in fundamentally sound companies with long term horizon.

In this issue:

  • Movers & Shakers
  • Market Outlook
  • Nifty Technical Outlook
  • Fundamental Stock
  • Auto Sales
  • Commodity Outlook
  • Mutual Fund
  • Key Financial Events – Oct

Nifty Technical Outlook October: On the monthly chart, we are observing two consecutive narrow body formations which resemble a Spinning top candlestick pattern. The said candlestick pattern suggests that the prior up trend is losing breath. In the coming month if Nifty trades and closes above 9884 level then it is likely to test 10027 – 10171 – 10338 levels. However, if Nifty trades and closes below 9692 level then it can test 9549 – 9406 – 9239 levels.

Broadly, we are of the opinion that for current month 9540 level remains make or break level. Hence, one can hold their long positions as long as Nifty holds the mentioned level.

Tags: Auto SalesKey EventsMutual FundMovers & ShakersCommodity OutlookNifty Technical OutlookFundamental Pick

Arihant's October Investment Newsletter is now available #‎ValuePlus
Click here to go through our flipbook now.
Click here to download full pdf report.

Search Reports



Daily Metal & Agro Buzz

HIGHLIGHTS: Natural gas...

Read More

Daily Market Update...

On 22/03/2018 markets opened...

Read More

Daily Metal & Agro Buzz:

HIGHLIGHTS: Cane arrears of...

Read More

Daily Currency Market...

HIGHLIGHTS: The dollar fell...

Read More

Daily Market Update...

On 21/03/2018 markets opened...

Read More



Read More



Read More

Century Textile

We have valued each segment...

Read More



Read More

Ajanta Pharma Initiating...

Ajanta Pharma (AJP) delivered...

Read More

Subscribe to newsletter

Request a call back

DISCLAIMER: This document has been prepared by Arihant Capital Markets Limited (hereinafter called as Arihant) and its subsidiaries and associated companies. This document does not constitute an offer or solicitation for the purchase and sale of any financial instrument by Arihant. This document has been prepared and issued on the basis of publicly available information, internally developed data and other sources believed to be reliable. Whilst meticulous care has been taken to ensure that the facts stated are accurate and opinions given are fair and reasonable, neither the analyst nor any employee of our company is in any way is responsible for its contents and nor is its accuracy or completeness guaranteed. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. Arihant Capital Markets Ltd (including its affiliates) or its officers, directors, personnel and employees, including persons involved in the preparation or issuance of this material may; (a) from time to time, have positions in, and buy or sell or (b) be engaged in any other transaction and earn brokerage or other compensation in the financial instruments/products discussed herein or act as advisor or lender/borrower in respect of such securities/financial instruments/products or have other potential conflict of interest with respect to any recommendation and related information and opinions.